Brief: Ikena Oncology Acquires Pionyr Immunotherapeutics

ImageneBio

07/08/2023 15:37

Aug 7 (Reuters) - Ikena Oncology Inc  IKNA.O :
    * IKENA ONCOLOGY ACQUIRES PIONYR IMMUNOTHERAPEUTICS IN
ALL-STOCK
TRANSACTION
    * IKENA ONCOLOGY INC - IKENA RECEIVES APPROXIMATELY $43
MILLION IN
NET CASH AT CLOSING
    * IKENA ONCOLOGY INC - IKENA'S MANAGEMENT TEAM AND BOARD OF
DIRECTORS REMAIN UNCHANGED
    * IKENA ONCOLOGY-ACQUIRED PIONYR IN EXCHANGE FOR SHARES OF
CO'S
STOCK IN COMBINATION OF STOCK, NON-VOTING CONVERTIBLE PREFERRED
STOCK AT $7.15 PER SHARE

Source text for Eikon:  ID:nGNX7YrsGK 
Further company coverage:  IKNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))